About Us

 

“The Age of Tissue Computing has Arrived™”

Brought to you by BCM Industries

Notice: The forthcoming annual production of millions of TOD™ system, with live Tissue Computing, utilized in commercial, industrial, business, research, government, military, space, gaming, deep data mining, home, and other applications, will directly and massively impact everything and everyone.

 

 

BCM Industries Inc. (BCM) has emerged as the technology and development leader in tissue engineering addressing the delivery of Autologous Regenerative Tissue Replacement (ARTR™) organ repair. ARTR™ products are designed to regenerate organ tissue for repair of the liver (CLD), kidney (CKD), pancreas (T1D and T2D), and the lungs (COPD). Expanding upon this leadership, BCM is developing a new autologous product, (ARTR™ TRANS) to provide organ patients, full and complete autologous organ transplants, without the need for donors matching, or any anti-rejection drugs.

Using these advanced tissue engineering technologies, experience, and skills, BCM recently focused upon addressing the need for computers that offer near blinding processing speed, and throughput, massive data storage capacity, and lighting fast data transfers. The natural solution is neuron populated live tissue, which can perform these tasks 1,000 times faster than a Classical digital computer.

However, neurons are live nerve cells, which presented two major problems. The first was, how to communicate with, and manage the actions of live neurons. The second was how to grow, sustain, and to provide computer users the millions of live neurons required to perform these advanced processing tasks and to provide massive data storage capacities.

The first issue was addressed with the development of a number of successful brain computer interface (BCI) devices. These devices can read and interpret the actions, the pulses, of live nervons. They can also deliver data and commands to the neurons. In simple terms, these BCI devices can read and write to a neuron and interpret neuron actions or language.

The second challenge was directly within the wheelhouse of the advanced tissue engineering technologies, experience, and skills held by BCM. The task was to design and develop the processes and systems to grow specialized neuron processing tissue disks, cords and arrays that were imbedded with bi-directions, read-write, live neurons that included highly extended cell life spans, and digital interfacing neuron processing functionality, all operating within a self-contained, portable, Tissue Computer (TC).

The complete system, the Tissue Operating Device (TOD™), uses digital computers and software to control and manage the TC and other system components. Offered in desktop towers, floor models, and rack mounted units, all TOD™ Models deliver lighting fast neuron processing and massive neuron data storage capacities. 

The forthcoming TOD™ family of nine tissue structured TC configurations will offer from 16 million to 5 billion live neurons to process and store data. Initial delivery of TOD™ Model 16 is scheduled for December 2022, with all nine Models available in 2023.

It is anticipated the forthcoming annual production of millions of TOD™ system, with live Tissue Computing, to be utilized in commercial, industrial, business, research, government, military, space, gaming, deep data mining, home, and other applications, will directly and massively impact everything and everyone.

 
BCM Lab with whiteglow100.png

“Innovative Products That Regenerate Quality Of Life”

BCM Logo FINAL trans50.png
  • LinkedIn
  • YouTube
  • Facebook